Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tcelna™, a novel T-cell therapy for multiple sclerosis (MS), today announced that Neil K. Warma, President and Chief Executive Officer, will present at the 15th Annual BIO CEO & Investor Conference on Monday, February 11, 2013, at 2:30 p.m. EST in the Conrad Room. The conference will be held at the Waldorf-Astoria Hotel in New York, NY.
